Neurology News and Research

Latest Neurology News and Research

Scientists identify new drugs that have potential to slow down progression of Parkinson's

New drugs which may have the potential to stop faulty brain cells dying and slow down the progression of Parkinson's, have been identified by scientists in a pioneering study which is the first of its kind.

4 Sep 2013

More young people show risk factors for common type of strokes

Fifteen percent of the most common type of strokes occur in adolescents and young adults, and more young people are showing risk factors for such strokes, according to a report in the journal Neurology.

4 Sep 2013

Prana's PBT2 drug recognised as one of the most promising treatments under development

Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, is pleased to announce Elsevier Business Intelligence has named clinical drug PBT2 as one of the Top 10 Neuroscience Projects to Watch.

3 Sep 2013

Ipsen announces results of phase III study of somatuline in patients with neuroendocrine tumors

Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the detailed results of phase III CLARINET study assessing the effect of Somatuline® Autogel® 120 mg in patients with gastrointestinal and pancreatic neuroendocrine tumors ("GEP-NETs")1 will be disclosed for the first time on September 28, 2013 at the European Cancer Congress 2013 (Sept. 27 - Oct. 1, 2013) in Amsterdam.

31 Aug 2013

Mayo Clinic tests feasibility of telemedicine robot to assess athletes during football games

There will be a new face at Northern Arizona University football games this fall - only this face will be on a robot on wheels.

31 Aug 2013

EEG marker unlikely to predict epilepsy death

Prolonged postictal generalized electroencephalography suppression is an “inconsistent” finding in patients with epilepsy, say researchers.

30 Aug 2013

European Commission approves Stivarga tablets for treatment of patients with mCRC

Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved Stivarga® (regorafenib) tablets for the treatment of adult patients with metastatic colorectal cancer (mCRC).

30 Aug 2013

NIHR recognizes Plymouth Hospitals for promoting clinical research in NHS

Healthcare professionals and academic researchers will have the opportunity to hear from research teams at Plymouth Hospitals NHS Trust and its research partners next month.

30 Aug 2013

Research team examines link between genetics and memory problems in Parkinson's patients

A research team at University of Virginia School of Medicine led by Matthew Barrett, MD, MSc, will use a state grant to examine the link between genetics and memory problems in Parkinson's disease patients. Barrett hopes the research will eventually lead to customized treatments for Parkinson's disease patients.

30 Aug 2013

Blood test provides tool essential to trials of therapies for Huntington's disease

An assay designed to measure normal and abnormal forms of the huntingtin protein - the mutated form of which causes Huntington's disease - was successful in detecting levels of the mutant protein in a large multicenter study of individuals at risk for the devastating neurological disorder.

30 Aug 2013

Study reveals relationship between migraine and low income status

Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.

29 Aug 2013

Study shows that migraine may have long-term effects on the brain's structure

Migraine may have long-lasting effects on the brain's structure, according to a study published in the August 28, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Aug 2013

Study: Deficiency of protein causes age-related memory loss and Alzheimer's disease

A team of Columbia University Medical Center (CUMC) researchers, led by Nobel laureate Eric R. Kandel, MD, has found that deficiency of a protein called RbAp48 in the hippocampus is a significant contributor to age-related memory loss and that this form of memory loss is reversible.

29 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

JHI signs agreement with HMV to enhance clinical care, patient safety and nursing education

Enhancements in clinical care and patient safety, medical research and nursing initiatives are at the core of a new affiliation agreement signed on Aug. 27 by Johns Hopkins Medicine International, Baltimore, USA, and Hospital Moinhos de Vento of Porto Alegre, one of Brazil’s leaders in health care delivery and innovation.

28 Aug 2013

Stroke patients with attention disorders can be helped by brain-training computer games

A majority of stroke patients have problems paying attention and could be helped by brain-training computer games, a new study suggests.

28 Aug 2013

'Helper cells' improve survival rate of transplanted stem cells, finds study

Like volunteers handing out cups of energy drinks to marathon runners, specially engineered "helper cells" transplanted along with stem cells can dole out growth factors to increase the stem cells' endurance, at least briefly, Johns Hopkins researchers report.

28 Aug 2013

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

27 Aug 2013

Comparison of guidelines highlights when player can resume athletic activity after concussion

Concussions are a common sports injury that can have long-term neurological consequences if not properly diagnosed and treated. Several new or updated guidelines for managing sports concussions were released earlier this year, and their key areas of consensus, including recommendations for return to play, are presented in an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

27 Aug 2013

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease.

27 Aug 2013

Neurology News and Research

Latest Neurology News and Research

Scientists identify new drugs that have potential to slow down progression of Parkinson's

More young people show risk factors for common type of strokes

Prana's PBT2 drug recognised as one of the most promising treatments under development

Ipsen announces results of phase III study of somatuline in patients with neuroendocrine tumors

Mayo Clinic tests feasibility of telemedicine robot to assess athletes during football games

EEG marker unlikely to predict epilepsy death

European Commission approves Stivarga tablets for treatment of patients with mCRC

NIHR recognizes Plymouth Hospitals for promoting clinical research in NHS

Research team examines link between genetics and memory problems in Parkinson's patients

Blood test provides tool essential to trials of therapies for Huntington's disease

Study reveals relationship between migraine and low income status

Study shows that migraine may have long-term effects on the brain's structure

Study: Deficiency of protein causes age-related memory loss and Alzheimer's disease

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

JHI signs agreement with HMV to enhance clinical care, patient safety and nursing education

Stroke patients with attention disorders can be helped by brain-training computer games

'Helper cells' improve survival rate of transplanted stem cells, finds study

FDA grants Priority Review designation to sNDA for Nexavar tablets

Comparison of guidelines highlights when player can resume athletic activity after concussion

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Neurology News and Research

Latest Neurology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in